| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/25/1999 | WO1999009164A1 Coding sequence haplotypes of the human brca2 gene |
| 02/25/1999 | WO1999009157A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/25/1999 | WO1999009061A1 Secreted proteins |
| 02/25/1999 | WO1999009049A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009046A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009030A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| 02/25/1999 | WO1999009016A1 Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors |
| 02/25/1999 | WO1999009006A1 SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF |
| 02/25/1999 | WO1999008994A1 Anti-cancer compounds |
| 02/25/1999 | WO1999008729A1 Loading and release of water-insoluble drugs |
| 02/25/1999 | WO1999008700A1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 02/25/1999 | WO1999008694A1 Immunostimulatory and metastasis inhibiting fermented vegetal material |
| 02/25/1999 | WO1999008692A1 Reovirus for the treatment of neoplasia |
| 02/25/1999 | WO1999008687A1 13-deoxyanthracycline derivatives and processes for preparing them |
| 02/25/1999 | WO1999008684A2 Solutions containing azasteroids |
| 02/25/1999 | WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 02/25/1999 | WO1999008668A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 02/25/1999 | WO1999008666A2 Pharmaceutical composition comprising an azateroid |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | WO1998049321A3 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 02/25/1999 | DE19833750A1 New thiazolyl-alkadienol and -epoxide derivatives |
| 02/25/1999 | DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds |
| 02/25/1999 | CA2303201A1 Vectors for treating cancer |
| 02/25/1999 | CA2301139A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins |
| 02/25/1999 | CA2301054A1 Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof |
| 02/25/1999 | CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | CA2300805A1 Polypeptide having a gtpase regulator activity, nucleic acids coding therefor and their use in diagnostics and therapy |
| 02/25/1999 | CA2300801A1 Rab proteins |
| 02/25/1999 | CA2298543A1 Loading and release of water-insoluble drugs |
| 02/25/1999 | CA2295023A1 Solutions containing azasteroids |
| 02/25/1999 | CA2295016A1 Pharmaceutical composition |
| 02/25/1999 | CA2241430A1 Novel murb |
| 02/24/1999 | EP0897987A2 Secretion of human protein linked to gamma interferon signal peptide |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897915A1 Quinazolinone conpounds as chemotherapeutic agents |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | EP0897720A1 Droloxifene for prevention of breast cancer |
| 02/24/1999 | EP0897424A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 02/24/1999 | EP0897389A1 Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes |
| 02/24/1999 | EP0897303A1 Inhibitors of farnesyl-protein transferase |
| 02/24/1999 | CN1209133A Phospholipid derivatives of phosphono-carboxylic acids, prodn. and use as antiviral |
| 02/24/1999 | CN1209129A Antagonists of gonadotropin releasing hormone |
| 02/24/1999 | CN1209127A Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 02/24/1999 | CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same |
| 02/24/1999 | CN1209120A 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof |
| 02/24/1999 | CN1209063A Vitronection receptor antagonists |
| 02/24/1999 | CN1209060A Vitronectin receptor antagonists |
| 02/24/1999 | CN1208616A Sustained release and implantation type cis-platinum medicine and method for preparing same |
| 02/24/1999 | CN1208613A Sustained release and implantation type doxorubicin medicine and method for preparing same |
| 02/24/1999 | CN1208612A Sustained release and implantation type methotrexate medicine and method for preparing same |
| 02/24/1999 | CN1208611A Sustained release and implantation type fluorouracil medicine and method for preparing same |
| 02/24/1999 | CN1208610A Sustained release and implantation type mitomycin medicine and method for preparing same |
| 02/24/1999 | CN1208609A Sustained release and implantation type antineoplasma medicine and method for preparing same |
| 02/23/1999 | US5874595 Single step, selective acetylation of 10-deacetylbaccatin iii into baccatin iii using lewis acid catalysts in the reaction with acetic anhydride; preparation of taxol from baccatin iii |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/23/1999 | US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
| 02/23/1999 | US5874536 Proteins with Oncostatin M activity and process for their preparation |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874529 Conformationally constrained backbone cyclized peptide analogs |
| 02/23/1999 | US5874473 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
| 02/23/1999 | US5874442 Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease |
| 02/23/1999 | US5874434 10,11-methanodibenzosuberane derivatives |
| 02/23/1999 | US5874412 Anticancer agents |
| 02/23/1999 | US5874402 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 02/23/1999 | US5874307 Process for induction culture of cytotoxic T lymphocytes having killing activity against tumor cells |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874271 Dna gene encoding as anticancer agent |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874248 Polynucleotides and codes |
| 02/23/1999 | US5874244 Human NADH dehydrogenase subunits and DNA thereof |
| 02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874081 Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | US5874076 Immunomodulators; antitumor,-carcinogenic agents; extracted from a recombinant microorganism; separated from reduced interleukin (cysteine) from the oxidized interleukin (cystine) |
| 02/23/1999 | CA2133594C Process of preparing etoposide phosphate and etoposide |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/18/1999 | WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 02/18/1999 | WO1999007891A1 90 human secreted proteins |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007840A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | WO1999007710A1 Macrolides with antitumor activity |
| 02/18/1999 | WO1999007709A1 Methods of preparing and purifying 9-nitro-20-camptothecin |
| 02/18/1999 | WO1999007705A1 Purine inhibitor of protein kinases, g proteins and polymerases |
| 02/18/1999 | WO1999007693A1 Benzothiophenes |
| 02/18/1999 | WO1999007692A2 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 02/18/1999 | WO1999007675A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 02/18/1999 | WO1999007668A1 Non-steroidal ligands for the estrogen receptor |